Stay updated on 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.8.0 to v3.8.1, while the study record content remains unchanged.
    Difference
    0.0%
    Check dated 2026-11-18T01:12:29.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The record describes a completed Phase 3 trial evaluating secukinumab versus placebo for active psoriatic arthritis, including its design, outcomes, eligibility criteria, locations, and data-sharing plan.
    Difference
    85%
    Check dated 2026-11-10T20:10:18.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T20:39:50.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A site-wide NIH notice about transitioning from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The clinical trial record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T20:57:06.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The footer revision identifier advances from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T20:37:52.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the previous study details, locations, and related content with an access notice. This reflects a shift from publicly viewable study information to an error page.
    Difference
    18%
    Check dated 2026-09-22T22:10:46.000Z thumbnail image

Stay in the know with updates to 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.